0001209191-17-065674.txt : 20171214 0001209191-17-065674.hdr.sgml : 20171214 20171214161353 ACCESSION NUMBER: 0001209191-17-065674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171213 FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Anthony L CENTRAL INDEX KEY: 0001635534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 171256335 MAIL ADDRESS: STREET 1: C/O GLOBUS MEDICAL, INC. STREET 2: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-13 0 0001237831 GLOBUS MEDICAL INC GMED 0001635534 Williams Anthony L 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 0 1 0 0 President Class A Common Stock 2017-12-13 4 M 0 15000 13.04 A 15000 D Class A Common Stock 2017-12-13 4 S 0 15000 38.2994 D 0 D Stock Option (Right to Buy Class A Common Stock) 13.04 2017-12-13 4 M 0 15000 0.00 D 2023-01-24 Class A Common Stock 15000 10000 D This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on November 13, 2017, which is intended to comply with Rule 10b5-1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.01 to $38.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Anthony L. Williams 2017-12-14